BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 15800226)

  • 1. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
    Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
    N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
    Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
    N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin, aspirin, and intracranial vascular disease.
    Koroshetz WJ
    N Engl J Med; 2005 Mar; 352(13):1368-70. PubMed ID: 15800233
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
    Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
    Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY; Zhang HP; Sun YH; Jiang LQ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
    Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
    Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
    Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
    Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.